Premier Research Expands its Medical Device Operations to the United States
PHILADELPHIA, March 11 /PRNewswire/-Premier Research Group Limited, the international clinical services group, is pleased to announce that it has expanded their medical device operations to include full coverage in the United States. Their dedicated medical device group has been offering clinical trials services in Europe since 1997 and is considered an industry leader for managing medical device trials and support services.
"Our clients have requested expanded medical device services, and we are committed to responding to these needs," explained Premier Research Group COO Dr. Troy McCall. "Providing both US and EU medical devices services is a strategic focus for our company and this will strengthen our ability to respond to customer's needs as well as offer a broader range of services for the global market."
U.S. medical device operations will be overseen by Efraim Roe Kozorovitsky, Executive Director, Medical Devices, and a 4-year veteran of the company. Mr. Roe has relocated from Switzerland to the United States. "Since July 2008, we have been establishing the infrastructure for our capabilities in the U.S. and today we are pleased to announce that we have the expertise in place to deliver the same quality that we have been providing in Europe for the past ten years. I look forward to growing this group," he commented.
About Premier Research
Premier Research is a leading global solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. They are leaders in clinical research for analgesia, neuroscience, oncology, and infectious disease and have a wealth of experience in medical device and pediatric research.
Premier Research has 30 offices and operates in more than 30 countries across North America and Europe employing more 1,200 clinical professionals dedicated first and foremost to fulfilling each client's requirements in a timely, accurate, and cost-effective manner. This includes a strong international network of monitors and project management professionals combined with regulatory, data management, statistical, scientific and medical experts, and staff at our well-established network of dedicated clinical sites.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
